Neuspera eyes FDA approval for urinary incontinence implant
Neuspera Medical has announced that its implantable sacral neuromodulation (SNM) system for treating urinary urge incontinence has met the primary…
Neuspera Medical has announced that its implantable sacral neuromodulation (SNM) system for treating urinary urge incontinence has met the primary…
Novo Nordisk has said it will take a DKr5.7bn ($816m) hit after its acquired drug ocedurenone flopped in the Phase…
DNA Diagnostics Centre (DDC) will supply a home test kit for sperm detection to Contraline’s first-in-human trial evaluating its male…
Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The…
French company Affluent Medical has completed the first successful implantation of its Artus device for the treatment of urinary incontinence.…
Following positive clinical results, the US Food Drug Administration (FDA) has granted SeaStar Medical a humanitarian device exemption (HDE) approval…
Travere Therapeutics has signed a licencing agreement for sparsentan with Japan-based Renalys Pharma for multiple Asian countries. As per the…
Vera Therapeutics has said that Phase II open-label expansion (OLE) study data gives extra confidence in the ongoing Phase III…
UroMems has reached another checkpoint in bringing the first automated artificial urinary sphincter to market after the company announced its…
Calliditas Therapeutics has initiated a Phase II trial to evaluate setanaxib as a treatment for Alport syndrome. The randomised, placebo-controlled…